Open AccessSINGLE-DOSE REGIMEN OF DACLIZUMAB IS AS EFFECTIVE AS TWO-DOSE REGIMEN FOR PREVENTION OF ACUTE REJECTION IN CHINESE KIDNEY TRANSPLANT RECIPIENTS.
Author(s) -
AUTHOR_ID
Publication year - 2006
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200607152-01304
Subject(s) - daclizumab , medicine , regimen , kidney transplant , kidney transplantation , kidney , intensive care medicine , transplantation , tacrolimus